Analyzing Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer
September 4th 2019Angela DeMichele, MD, MSCE, discusses predictors of response to neoadjuvant chemotherapy in various subgroups of patients with breast cancer. Selecting characteristics of patients who will most likely benefit from this therapy is not an exact science, she adds.